An Evaluation of the Safety and Efficacy of LIPO-102 for the Reduction of Subcutaneous Abdominal Adiposity

Status:
Completed

Trial end date:
2010-03-01

Target enrollment:

Participant gender:

This is a double-masked evaluation of the safety and efficacy of LIPO-102 for the reduction of subcutaneous abdominal adiposity.

Phase 2

Neothetics, Inc